According to The Cancer Genome Atlas (TCGA), the three main KRAS mutations of lung adenocarcinoma [69,70] are G12C (10–13%), G12V (5–6%) and G12D (4–5%). This evidence concerns the gene KRAS and lung adenocarcinoma.